Keyword Analysis & Research: myeloma stem cell transplant prognosis
Keyword Research: People who searched myeloma stem cell transplant prognosis also searched
Search Results related to myeloma stem cell transplant prognosis on Search Engine
-
Long-Term Survival for Myeloma after Autologous Stem Cell
https://ashpublications.org/blood/article/136/Supplement%201/23/472082/Long-Term-Survival-for-Myeloma-after-Autologous
WEBNov 5, 2020 · Conclusions: ASCT is associated with durable responses and prolonged survival in a subgroup of MM patients irrespective of type of induction therapy and/or use of maintenance therapy. Duration of remission after transplant is the strongest predictor for long-term survival.
DA: 79 PA: 1 MOZ Rank: 87
-
Multiple Myeloma Stem Cell Transplant: What to Expect - Healthline
https://www.healthline.com/health/managing-multiple-myeloma/multiple-myeloma-stem-cell-transplant
WEBJun 11, 2021 · Effectiveness and survival rates. Survival rates for cancer, including multiple myeloma, are often measured as a 5-year relative survival rate. This is the percentage of people with multiple...
DA: 16 PA: 92 MOZ Rank: 79
-
Long-term outcomes after autologous stem cell transplantation for
https://ashpublications.org/bloodadvances/article/4/2/422/440753/Long-term-outcomes-after-autologous-stem-cell
WEBJan 28, 2020 · Key Points. Long-term survival in MM patients treated with ASCT has improved with the introduction of novel therapeutics. Outcomes for older patients and those with low-risk disease improved, but those with high-risk disease still experience poor survival. Visual Abstract. View large Download slide. Abstract.
DA: 66 PA: 77 MOZ Rank: 91
-
Stem Cell Transplant for Multiple Myeloma - American Cancer Society
https://www.cancer.org/cancer/types/multiple-myeloma/treating/stem-cell-transplant.html
WEBThat’s because transplanted (donor) cells may actually help destroy myeloma cells. This is called a graft vs. tumor effect. In studies of multiple myeloma patients, those who got allogeneic transplants often did worse in the short term than those who got …
DA: 34 PA: 39 MOZ Rank: 23
-
Stem Cell Transplant for Multiple Myeloma - Verywell Health
https://www.verywellhealth.com/stem-cell-transplant-for-multiple-myeloma-5210131
WEBNov 30, 2021 · The survival of multiple myeloma with stem cell transplant is substantially improved. About 10%–18% of people have a normal life expectancy with this treatment and approximately 72% do not have disease progression within three years.
DA: 6 PA: 50 MOZ Rank: 60
-
Improved progression-free survival in patients with multiple myeloma
https://www.dana-farber.org/newsroom/news-releases/2022/improved-progression-free-survival-in-patients-with-multiple-myeloma-following-three-drug-therapy-with-autologous-stem-cell-transplant
WEBJun 5, 2022 · While an autologous stem cell transplant yielded a longer progression-free survival (PFS) – the length of time patients are alive with no relapse of their cancer – the high doses of the chemotherapy drug melphalan given in advance of a transplant significantly increase patients’ risk of developing secondary leukemia and …
DA: 41 PA: 89 MOZ Rank: 12
-
Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem
https://ashpublications.org/blood/article/136/Supplement%201/24/472089/Survival-Trends-in-Multiple-Myeloma-after
WEBNov 5, 2020 · Primary endpoints were 5-year overall survival (OS) and progression-free survival (PFS). Secondary endpoints were cumulative incidence of relapse (CIR) and non-relapse mortality (NRM). The Kaplan-Meier method was used to estimate OS and PFS.
DA: 82 PA: 66 MOZ Rank: 97
-
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
https://www.nature.com/articles/s41408-023-00900-z
WEBAug 18, 2023 · Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who...
DA: 48 PA: 99 MOZ Rank: 18
-
Analysis of long‐term survival in multiple myeloma after first‐line
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806105/
WEBDec 28, 2017 · The widespread use of high‐dose therapy and autologous stem cell transplantation ( ASCT) as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma ( MM) enabling long‐term survival.
DA: 95 PA: 64 MOZ Rank: 5
-
Stem Cell Transplant for Multiple Myeloma | Memorial Sloan …
https://www.mskcc.org/cancer-care/types/multiple-myeloma/multiple-myeloma-treatment/stem-cell-transplantation
WEBFull recovery takes several months. When they work well, autologous and allogeneic transplants give you a new, healthy bone marrow. Allogeneic transplants also give you a new immune system, built from your donor’s stem cells. Your new immune system may help protect you against cancer. Gut microbiota and transplants.
DA: 49 PA: 70 MOZ Rank: 59
